Drug Trial Radar · NCT03622060
Intraarterial Nitroglycerin Versus Nicardipine and Radial Artery Occlusion
Last checked: Nov 20, 2026Latest source record: Jun 4, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
600
Actual
Start
Jun 4, 2018
Primary completion
May 21, 2019
Study completion May 22, 2019
Sponsor
- Lead sponsor
- Hermina Heart Center KemayoranAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Hermina Hospital Group
- First posted
- Aug 9, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 16 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A total of 600 patients undergoing coronary procedures via transradial access using 6F sheath were randomized at the end of the procedure to receive either 250-µg nicardipine or 500-µg nitroglycerin administered to the radial artery through the radial sheath before sheath removal. A continuous patent hemostasis was applied in each patient with the use of an oximetry to maintain an oxygen saturation of \>95%, measured in the finger of the accessed arm until compression device was totally removed. The primary outcome is early RAO which was evaluated by color duplex ultrasonography of the accessed arteries at the day after the radial procedure. Secondary outcome was the change of blood pressure at 2-3 minutes after drug administration. Radial artery angiogram was performed after radial sheath insertion and doppler ultrasound of the accesed radial artery was examined at the day after the procedure.
Conditions
- Radial Artery Injury at Wrist and Hand Level
- Occlusion of Artery
- Vasodilation
Interventions
NitroglycerinDrug
200 microgram intraarterial nicardipine and 500 microgram nitroglycerin administered before sheath removal
Primary outcomes
What the sponsor says the trial is designed to measure.
- The absence of antegrade radial artery flow by doppler evaluationTime frame: 24 hour
- Blood pressure changeTime frame: 2 minutes after drugs administration
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hermina Heart Center
Jakarta Pusat, DKI Jakarta, Indonesia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.